Feiye Zhou

474 total citations
21 papers, 342 citations indexed

About

Feiye Zhou is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Feiye Zhou has authored 21 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Surgery and 7 papers in Physiology. Recurrent topics in Feiye Zhou's work include Pancreatic function and diabetes (10 papers), Adipose Tissue and Metabolism (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Feiye Zhou is often cited by papers focused on Pancreatic function and diabetes (10 papers), Adipose Tissue and Metabolism (7 papers) and Metabolism, Diabetes, and Cancer (6 papers). Feiye Zhou collaborates with scholars based in China. Feiye Zhou's co-authors include Libin Zhou, Qin Zhu, Shushu Wang, Ke-Cheng Zhu, Ruyuan Deng, Linlin Zhang, Qianqian Liu, Yun Liu, Xiao Wang and Xiao Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research and Life Sciences.

In The Last Decade

Feiye Zhou

21 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feiye Zhou China 14 203 78 65 65 53 21 342
Miriayi Alimujiang China 9 175 0.9× 93 1.2× 47 0.7× 107 1.6× 57 1.1× 14 343
Cecilia-Hsuan Day Taiwan 11 161 0.8× 85 1.1× 24 0.4× 62 1.0× 35 0.7× 12 325
Adnan Erol Türkiye 13 194 1.0× 150 1.9× 60 0.9× 88 1.4× 46 0.9× 24 473
Prashanth Chandramani-Shivalingappa United States 5 164 0.8× 77 1.0× 44 0.7× 133 2.0× 28 0.5× 7 421
Vadim Nudelman Israel 8 196 1.0× 115 1.5× 79 1.2× 58 0.9× 119 2.2× 8 432
Junmei Ye China 14 223 1.1× 75 1.0× 27 0.4× 63 1.0× 16 0.3× 27 431
Kejing Zeng Canada 7 179 0.9× 116 1.5× 57 0.9× 129 2.0× 92 1.7× 8 369
Hye-Na Cha South Korea 11 158 0.8× 130 1.7× 24 0.4× 97 1.5× 28 0.5× 19 386
You Na China 6 175 0.9× 62 0.8× 33 0.5× 130 2.0× 31 0.6× 8 364
Weicheng Zhao China 12 110 0.5× 114 1.5× 55 0.8× 27 0.4× 27 0.5× 21 414

Countries citing papers authored by Feiye Zhou

Since Specialization
Citations

This map shows the geographic impact of Feiye Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiye Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiye Zhou more than expected).

Fields of papers citing papers by Feiye Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feiye Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiye Zhou. The network helps show where Feiye Zhou may publish in the future.

Co-authorship network of co-authors of Feiye Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Feiye Zhou. A scholar is included among the top collaborators of Feiye Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feiye Zhou. Feiye Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Tianjiao, Hong Lin, Feiye Zhou, et al.. (2025). Hepatic CBP/p300 Orchestrate Amino Acid‐Driven Gluconeogenesis through Histone Crotonylation. Advanced Science. 12(41). e07635–e07635. 1 indexed citations
2.
Zhou, Feiye, Tianjiao Li, Xing Ming, et al.. (2024). BCKDH kinase promotes hepatic gluconeogenesis independent of BCKDHA. Cell Death and Disease. 15(10). 736–736. 4 indexed citations
3.
Wang, Shushu, Miaomiao Yuan, Linlin Zhang, et al.. (2022). Sodium butyrate potentiates insulin secretion from rat islets at the expense of compromised expression of β cell identity genes. Cell Death and Disease. 13(1). 67–67. 19 indexed citations
4.
Wang, Yiru, Feiye Zhou, Mingzhu Li, et al.. (2022). MiR-34a-5p promotes hepatic gluconeogenesis by suppressing SIRT1 expression. Experimental Cell Research. 420(1). 113336–113336. 8 indexed citations
5.
Zhou, Feiye, et al.. (2022). Calycosin-7-O-β-D-glucoside attenuates palmitate-induced lipid accumulation in hepatocytes through AMPK activation. European Journal of Pharmacology. 925. 174988–174988. 10 indexed citations
6.
Zhang, Linlin, Feiye Zhou, Shushu Wang, et al.. (2021). CBP/p300 HAT maintains the gene network critical for β cell identity and functional maturity. Cell Death and Disease. 12(5). 476–476. 14 indexed citations
7.
Zhou, Feiye, Linlin Zhang, Ke-Cheng Zhu, et al.. (2021). SIRT2 ablation inhibits glucose-stimulated insulin secretion through decreasing glycolytic flux. Theranostics. 11(10). 4825–4838. 31 indexed citations
8.
Wang, Shushu, Linlin Zhang, Feiye Zhou, et al.. (2020). Protein acetylation derepresses Serotonin Synthesis to potentiate Pancreatic Beta-Cell Function through HDAC1-PKA-Tph1 signaling. Theranostics. 10(16). 7351–7368. 11 indexed citations
9.
Zhou, Feiye, Qianqian Liu, Linlin Zhang, et al.. (2020). Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis. Cell Death and Disease. 11(9). 745–745. 28 indexed citations
10.
Xu, Wan, et al.. (2020). Leonurine protects against dexamethasone-induced cytotoxicity in pancreatic β-cells via PI3K/Akt signaling pathway. Biochemical and Biophysical Research Communications. 529(3). 652–658. 15 indexed citations
11.
Ji, Xueying, Shushu Wang, Feiye Zhou, et al.. (2019). PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis. Metabolism. 98. 62–75. 23 indexed citations
12.
Zhou, Feiye, Yun Liu, Linlin Zhang, et al.. (2019). The pivotal role of protein acetylation in linking glucose and fatty acid metabolism to β-cell function. Cell Death and Disease. 10(2). 66–66. 44 indexed citations
13.
Zhang, Qi, Qin Zhu, Ruyuan Deng, et al.. (2019). MS-275 induces hepatic FGF21 expression via H3K18ac-mediated CREBH signal. Journal of Molecular Endocrinology. 62(4). 187–196. 11 indexed citations
14.
Zhang, Yumei, Juan Zhang, Feiye Zhou, et al.. (2019). Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion. Toxicology Letters. 320. 19–27. 13 indexed citations
15.
Zhou, Feiye, Xiaofeng Wang, Bei Tao, et al.. (2019). SIRT2 deficiency prevents age-related bone loss in rats by inhibiting osteoclastogenesis. Cellular and Molecular Biology. 65(7). 66–71. 16 indexed citations
16.
Zhang, Linlin, Feiye Zhou, Qin Zhu, et al.. (2018). Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice. Life Sciences. 217. 185–192. 18 indexed citations
17.
Ji, Xueying, Feiye Zhou, Yuqing Zhang, et al.. (2018). Butyrate stimulates hepatic gluconeogenesis in mouse primary hepatocytes. Experimental and Therapeutic Medicine. 17(3). 1677–1687. 24 indexed citations
18.
Zhou, Feiye, Yuqing Zhang, Qin Zhu, et al.. (2017). Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77. Biochemical and Biophysical Research Communications. 495(2). 1936–1941. 18 indexed citations
19.
Zhou, Feiye, Ruyuan Deng, Xueying Ji, et al.. (2016). Glucose enhances rat islet function via stimulating CART expression. Biochemical and Biophysical Research Communications. 481(1-2). 84–89. 3 indexed citations
20.
Yang, Xue, Ruyuan Deng, Yun Liu, et al.. (2016). Potential role of Hsp90 in rat islet function under the condition of high glucose. Acta Diabetologica. 53(4). 621–628. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026